TETRAULT LYNN A.
SEC insider (Form 3/4/5 filer). CIK 0001645512. Director at ALUMIS INC. (ALMS) and 3 other issuers. 28 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies TETRAULT LYNN A. has filed insider reports for
- ALUMIS INC. (ALMS): Director
- RHYTHM PHARMACEUTICALS, INC. (RYTM): Director
- NEOGENOMICS INC (NEO): Director
- ACELYRIN, Inc. (SLRN): Director
TETRAULT LYNN A.
CIK: 0001645512
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (28 total)
- Jun 30, 2026ALMS
ALUMIS INC.
AwardDirect3.6K shares- - Jun 24, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
AwardDirectStock Option (right to buy)
3.7K shares- - Jun 24, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
2.3K shares- - Jun 23, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
ExerciseDirect4.7K shares- - Jun 22, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
SaleDirect37K shares at avg. $100.32$3.7M - Jun 22, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
ExerciseDirect37K shares at avg. $28.27$1.0M - Jun 15, 2026NEO
NEOGENOMICS INC
SaleDirect5.3K shares at avg. $11.10$59K - Jun 9, 2026NEO
NEOGENOMICS INC
SaleDirect5.3K shares at avg. $11.29$60K - Jun 1, 2026NEO
NEOGENOMICS INC
AwardDirectStock Option (Right to Buy)
11.1K shares- - Jun 1, 2026NEO
NEOGENOMICS INC
ExerciseDirect23.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 30, 2026 |  ALMS ALUMIS INC. | Award | 3,553 | - | $0 | Direct |
| Jun 24, 2026 |  RYTM RHYTHM PHARMACEUTICALS, INC. | Award Stock Option (right to buy) | 3,691 | - | - | Direct |
| Jun 24, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Award Restricted Stock Units | 2,324 | - | - | Direct |
| Jun 23, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise | 4,712 | - | $0 | Direct |
| Jun 22, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale | 37,000 | $100.32 | $3,711,896 | Direct |
| Jun 22, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise | 37,000 | $28.27 | $1,045,990 | Direct |
| Jun 15, 2026 |  NEO NEOGENOMICS INC | Sale | 5,307 | $11.10 | $58,908 | Direct |
| Jun 9, 2026 | NEO NEOGENOMICS INC | Sale | 5,307 | $11.29 | $59,916 | Direct |
| Jun 1, 2026 | NEO NEOGENOMICS INC | Award Stock Option (Right to Buy) | 11,069 | - | - | Direct |
| Jun 1, 2026 | NEO NEOGENOMICS INC | Exercise | 23,077 | - | $0 | Direct |
1-10 of 28 transactions